Middle East IVD Market Growth Stats

The projected CAGR for the in vitro diagnostics (IVD) market in the GCC countries is approximately 5.10% from 2025 to 2030. This estimate is based on market research from Mordor Intelligence, which forecasts growth from USD 2.18 billion in 2025 to USD 2.79 billion by 2030.

 Market Overview: GCC In Vitro Diagnostics (IVD)

2.18
Billion USD

2025 Market Size

2.79
Billion USD

2030 Market Size

JOIN US

5.1%
CAGR

Compound Annual Growth Rate ( 2025-2030)

Key Growth Divers

  • Rising prevalence of chronic diseases (e.g., diabetes, cardiovascular conditions)

  • Expanding healthcare infrastructure across Saudi Arabia, UAE, Qatar, and other GCC nations

  • Government initiatives to improve early disease detection and healthcare outcomes

  • Government Initiatives: Vision 2030 (Saudi Arabia) and similar national strategies are accelerating healthcare modernization

 Broader Middle East Context

For the broader Middle East region (beyond GCC), Grand View Research projects a CAGR of 7.25% from 2025 to 2033, with market size growing from USD 2.09 billion in 2024 to USD 3.80 billion by 2033. This higher growth rate reflects additional momentum from emerging markets and increased adoption of molecular diagnostics and point-of-care testing.

Source: Grand View Research